SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-08-234741
Filing Date
2008-11-13
Accepted
2008-11-13 12:01:13
Documents
5
Period of Report
2008-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 295530
2 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 4969
3 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 4963
4 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 3385
5 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 3381
  Complete submission text file 0001193125-08-234741.txt   313758
Mailing Address 2850 TELEGRAPH AVENUE SUITE 310 BERKELEY CA 94705
Business Address 2850 TELEGRAPH AVENUE SUITE 310 BERKELEY CA 94705 (510) 281-7700
Nile Therapeutics, Inc. (Filer) CIK: 0001133869 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34058 | Film No.: 081183585
SIC: 2834 Pharmaceutical Preparations